SNCA and Parkinson disease: Further, considering high prevalence of cognitive or psychiatric problems in PD with SNCA mutations (Book et al., 2018; Wittke et al., 2018), long‐term outcome of STN DBS is important when we take DBS into account as a possible treatment option in PD patients from SNCA mutations.